Azabicyclic sulfonamides as potent 11β-HSD1 inhibitors
2010
Abstract Inhibition of 11β-HSD1 has demonstrated potential in the treatment of various components of metabolic syndrome. We wish to report herein the discovery of novel azabicyclic sulfonamide based 11β-HSD1 inhibitors. Highly potent compounds exhibiting inhibitory activities at both human and mouse 11β-HSD1 were identified. Several compounds demonstrated significant in vivo activity in the mouse cortisone challenge assay.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
8
Citations
NaN
KQI